期刊文献+

非亲缘关系脐带血移植治疗25例血液系统疾病患者的临床研究 被引量:1

Clinical Study of Unrelated Umbilical Cord Blood Transplantation for 25 Patients with Hematological Diseases
下载PDF
导出
摘要 本研究观察非亲缘脐带血造血干细胞移植(UCBT)在血液系统疾病患者的植入率、移植物抗宿主病(GVHD)、移植相关死亡(TRM)、复发和生存情况。25例接受UCBT的血液系统疾病患者(儿童8例、成人17例)中。3例接受单份脐带血(CB),22例接受双份脐带血。供/受体低分辨人类白细胞抗原(HLA)配型结果为9例6/6位点相合、16例4-5/6位点相合。在预处理方案中21例采用TBI/Cy±Flu±ATG或BuCy±Flu±ATG,4例采用FC+ATG方案。移植物抗宿主病(GVHD)的预防采用以环孢素(CsA)为主的方案。结果表明,存活超过42 d的20例患者中16例(80.0%)获得植入;粒系植入至移植后42 d的累积发生率为64.0%,中位时间17.0 d;巨核系植入至移植后100 d的累积发生率为60.0%,中位时间35.0 d;II-IV度、III-IV度急性GVHD(aGVHD)至移植后100 d的累积发生率分别为44.0%和30.7%;截止至随访结束日期,移植相关死亡率(TRM)的累积发生率为54.3%;25例患者的总生存率为42.7%;17例可评估恶性血液病患者中7例(41.2%)存活,且仅有1例复发,无事件生存率(EFS)为35.3%;5例可评估的非恶性血液病患者中4例存活,2例处于持续脐血植入状态,2例自身造血恢复;处于疾病进展期的3例患者中仅1例患者存活。结论:低分辨HLA-4-6/6位点相合的UCBT治疗血液系统疾病是可行的,双份脐血移植(dUCBT)可以克服单份脐血细胞数量不足的缺点,可用于治疗大体重儿童及成人患者。 This study was purposed to investigate the engraftment, graft-versus-host disease (GVHD), transplantation related mortality (TRM), relapse and survival in hematologic patients received unrelated umbilical cord blood transplantation (UCBT). A total of 25 patients with hematological disease underwent UCBT, including 8 pediatric and 17 young adult patients. Among them 3 cases received single unit of UCBT and 22 cases received double units of UCBT. For donor/recipients human leukocyte antigen (HLA) matching: HLA 6/6 loci matched in 9 cases, HLA 4 -5/6 loci matched in 16 cases. There were 19 patients with hematologic malignancies, including 3 cases in the period of disease progression and 6 cases of non-hematologic malignancies. Conditioning regimens were TBI/Cy + Flu + ATG or BuCy + Flu + ATG for 21 patients and Cy + Flu + ATG for 4 patients. For prophylaxis of acute graft-versus-host disease (aGVHD) the regimen of cyclosporine (CsA) as dominant drug was used. The results showed that among 16 patients ( 80.0% ) achieved engraftment, 20 patients survived for more than 42 d after transplantation. The cumulative neutrophil recovery rate on day 42 after transplant was 64.0%, with a median time of 17.0 d;the cumulative platelet recovery rateon day 100 after transplant was 60.0 % ,with a median time of 35.0 d. The cumulative rate of grade Ⅱ - IV and Ⅲ - IV aGVHD after transplantation 100 d was 44.0% and 30. 7%, respectively. Until the end of the follow-up, the cumulative rate of TRM was 54. 3%. For all the patients, overall survival rate was 42. 7%. Out of 17 evaluable patients with hematologic malignancies 7 cases (41.2%) survived to date, and only 1 case relapsed, so event-free survival rate was 35. 3 %. Out of 5 evaluable patients with non-hematologic malignancies, 4 patients survived and 2 patients were in stable engraftment state, 2 cases with autologous hematopoietic recovery. Among 3 cases of hematologic malignancies at advanced stage, only 1 case survived to date. It is concluded that HLA-4 - 6/6 loci matched UCBT is an effective option to treat hematological diseases. Double cord blood transplantation (dUCBT) can overcome the disadvantage of insufficient cells of single cord blood UCBT to treat overweight children and adult.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2014年第3期767-773,共7页 Journal of Experimental Hematology
基金 江苏高校优势学科建设工程资助项目(2010) 江苏省临床医学中心项目(ZX201102) 国家自然科学基金项目(81270617) 上海市科技创业中心创新基金项目(1002H103000)
关键词 异基因造血干细胞移植 脐带血移植 血液系统疾病 allogeneic hematopoietic stem cell transplantation umbilical cord blood transplantation hematologicaldisease
  • 相关文献

参考文献17

  • 1Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hemapoietic reconstitution in a patient with fanconis anemia by means of umbilical cord blood from an HLA-identical sibling. N Engl J Med, 1989; 321(17): 1174-1178.
  • 2Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood,2001 ;97 (10) :2962 - 2971.
  • 3Barker JN, Davies SM, DeFor TE, et al. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched pair analysis. Blood, 2001 ;97(10) :2957 -2961.
  • 4张之南,沈悌.血液病诊断及疗效标准[M].2版.北京:人民卫生出版社,2007:232-235.
  • 5成人急性髓系白血病(非急性早幼粒细胞白血病)中国诊疗指南(2011年版)[J].中华血液学杂志,2011,32(11):804-807. 被引量:183
  • 6Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood, 2005 ; 105(3) :1343 - 1347.
  • 7Godstein G, Elhasid R, Bieloraia B, et al. Adults requiring cord blood transplants but have insufficient cell doses from a single cordblood unit can receive two units with successful engraftment kinetics similar to those of children receiving a single unit. Leukemia & Lymphoma, 2011; 52(4): 635-641.
  • 8王翠翠,孙自敏,刘会兰,耿良权,王兴兵,丁凯阳,汤宝林,童娟,王祖贻.非血缘双份脐血移植植入规律及植入动力学研究[J].白血病.淋巴瘤,2012,21(6):345-348. 被引量:1
  • 9Storb R,Etzioni R, Anasetti C, et al. Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood, 1994 ;84 (3) :94 - 949.
  • 10Lucarelli G, Clift RA, Galimberti M, et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood, 1996; 87(5) : 2082-2088.

二级参考文献13

  • 1王蕊,温丙昭,曲建华,江明,李玲,郭新红,陈王容,迪里娜孜·阿不来提,丁凌录.ABO血型不合的外周血干细胞移植及输血[J].白血病.淋巴瘤,2004,13(3):139-141. 被引量:9
  • 2齐(王君),张梅.脐血移植临床研究进展[J].白血病.淋巴瘤,2005,14(3):180-183. 被引量:3
  • 3Barker JN, Weisdorf D J, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood, 2005, 105: 1343-1347.
  • 4Thiede C, Florek M, Bornhauser M, et al. Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant, 1999, 23:1055-1060.
  • 5Claudio G, Brunstein, Juliet N, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact ontransplantation outcomes in 110 adults with hematologic disease. Blood, 2007,110:3064-3070.
  • 6Sufliarska S, Minarik G, Horkova J, et al. Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin. Neoplasma, 2007, 54:424-430.
  • 7Ariffin H,Daud SS, Mohamed Z, et al. Evaluation of two short tandem multiplex systems for posthaematopoietic stem cell transplantation chimerism analysis. Singapore Med J, 2007, 48:333.
  • 8Kang HJ, Kho SH, Jang MK, et al. Early engraftment kinetics of two units cord blood transplantation. Bone Marrow Transplant, 2006, 38: 197-201.
  • 9Brunstein CG, Barker JN, Weisdorf DJ, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning', impact on transplantation outcomes in 110 adults with hematologic disease. Blood, 2007, 110:3064-3070.
  • 10Arachchillage DR, Dalley CD, Reilly JT, et al. Long-term dual donor derived haematopoietic reconstitution following double unrelated cord blood transplantation-single unit dominance is not always the case .Br J Hematol, 2010, 149:298-299.

共引文献201

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部